InsidersTradesSigma
Browse the full record of transactions filed by Ulf Hannelius, 董事长兼首席执行官. Director active across 2 companies, notably Diamyd Medical AB. In total, 1 reports have been published. History available since 5 May 2025. The latest transaction was filed on 5 May 2025 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Ulf Hannelius is the Chief Executive Officer of Diamyd Medical AB. He is responsible for the strategic direction of the company, overseeing its operations and ensuring performance objectives are met. Ulf plays a key role in developing innovative medical solutions.